Age-dependent implications of left ventricular hypertrophy regression in patients with hypertension

Left ventricular hypertrophy (LVH) is a significant risk factor for cardiovascular mortality and morbidity in patients with hypertension. However, the effect of age on LVH regression or persistence and its differential prognostic value remain unclear. Therefore, we investigated the clinical implicat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Hypertension research 2024-05, Vol.47 (5), p.1144-1156
Hauptverfasser: Chu, Hyun-Wook, Hwang, In-Chang, Kim, Hyue Mee, Park, Jiesuck, Choi, Hyejung, Choi, Hong-Mi, Yoon, Yeonyee E, Cho, Goo-Yeong
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1156
container_issue 5
container_start_page 1144
container_title Hypertension research
container_volume 47
creator Chu, Hyun-Wook
Hwang, In-Chang
Kim, Hyue Mee
Park, Jiesuck
Choi, Hyejung
Choi, Hong-Mi
Yoon, Yeonyee E
Cho, Goo-Yeong
description Left ventricular hypertrophy (LVH) is a significant risk factor for cardiovascular mortality and morbidity in patients with hypertension. However, the effect of age on LVH regression or persistence and its differential prognostic value remain unclear. Therefore, we investigated the clinical implications of LVH regression in 1847 patients with hypertension and echocardiography data (at baseline and during antihypertensive treatment at an interval of 6-18 months) according to age. LVH was defined as a left ventricular mass index (LVMI) > 115 g/m and >95 g/m in men and women, respectively. LVH prevalence at baseline was not different according to age (age < 65 years: 42.6%; age ≥65 years: 45.7%; p = 0.187), but LVH regression was more frequently observed in the younger group (36.4% vs. 27.5%; p = 0.008). Spline curves and multiple linear regression analysis showed a significant relationship between reductions in systolic blood pressure and LVMI in the younger group (β = 0.425; p 
doi_str_mv 10.1038/s41440-023-01571-w
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2929059141</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2929059141</sourcerecordid><originalsourceid>FETCH-LOGICAL-c303t-c4956431b7dab8c78bd8f65dc64750953d3f4f28e95787d4f67be888b3ba12723</originalsourceid><addsrcrecordid>eNo9kDtPwzAYRS0EoqXwBxiQRxaDX4ntsUK8pEosMFuJ87k1ygs7oeq_J6WF6Q733DschK4ZvWNU6PskmZSUUC4IZZliZHuC5kxITSRn8hTNqWE5MbnIZ-gipU9Kuc4MO0czobnQGWNz5JZrIBX00FbQDjg0fR1cMYSuTbjzuAY_4O-picGNdRHxZtdDHGLXb3Y4wjpCShOLQ4v7aTWBCW_DsDly0O7bS3TmizrB1TEX6OPp8f3hhazenl8fliviBBUDcdJkuRSsVFVRaqd0WWmfZ5XLpcqoyUQlvPRcg8mUVpX0uSpBa12KsmBccbFAt4ffPnZfI6TBNiE5qOuihW5Mlhtu6CRAsgnlB9TFLqUI3vYxNEXcWUbtXq49yLWTXPsr126n0c3xfywbqP4nfzbFD-rNd5Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2929059141</pqid></control><display><type>article</type><title>Age-dependent implications of left ventricular hypertrophy regression in patients with hypertension</title><source>Alma/SFX Local Collection</source><creator>Chu, Hyun-Wook ; Hwang, In-Chang ; Kim, Hyue Mee ; Park, Jiesuck ; Choi, Hyejung ; Choi, Hong-Mi ; Yoon, Yeonyee E ; Cho, Goo-Yeong</creator><creatorcontrib>Chu, Hyun-Wook ; Hwang, In-Chang ; Kim, Hyue Mee ; Park, Jiesuck ; Choi, Hyejung ; Choi, Hong-Mi ; Yoon, Yeonyee E ; Cho, Goo-Yeong</creatorcontrib><description>Left ventricular hypertrophy (LVH) is a significant risk factor for cardiovascular mortality and morbidity in patients with hypertension. However, the effect of age on LVH regression or persistence and its differential prognostic value remain unclear. Therefore, we investigated the clinical implications of LVH regression in 1847 patients with hypertension and echocardiography data (at baseline and during antihypertensive treatment at an interval of 6-18 months) according to age. LVH was defined as a left ventricular mass index (LVMI) &gt; 115 g/m and &gt;95 g/m in men and women, respectively. LVH prevalence at baseline was not different according to age (age &lt; 65 years: 42.6%; age ≥65 years: 45.7%; p = 0.187), but LVH regression was more frequently observed in the younger group (36.4% vs. 27.5%; p = 0.008). Spline curves and multiple linear regression analysis showed a significant relationship between reductions in systolic blood pressure and LVMI in the younger group (β = 0.425; p &lt; 0.001), but not the elderly group (β = 0.044; p = 0.308). LVH regression was associated with a lower risk of the study outcome (composite of cardiovascular death and hospitalization for heart failure) regardless of age. In conclusion, the association between the reduction in blood pressure and LVH regression was prominent in patients with age &lt; 65 years, but not in those with age ≥65 years. However, an association between LVH regression and lower risk of cardiovascular death and hospitalization for heart failure was observed regardless of patient age, suggesting the prognostic value of the LVH regression not only in the younger patients but also in elderly patients.</description><identifier>ISSN: 0916-9636</identifier><identifier>EISSN: 1348-4214</identifier><identifier>DOI: 10.1038/s41440-023-01571-w</identifier><identifier>PMID: 38238511</identifier><language>eng</language><publisher>England</publisher><ispartof>Hypertension research, 2024-05, Vol.47 (5), p.1144-1156</ispartof><rights>2024. The Author(s), under exclusive licence to The Japanese Society of Hypertension.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c303t-c4956431b7dab8c78bd8f65dc64750953d3f4f28e95787d4f67be888b3ba12723</citedby><cites>FETCH-LOGICAL-c303t-c4956431b7dab8c78bd8f65dc64750953d3f4f28e95787d4f67be888b3ba12723</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38238511$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chu, Hyun-Wook</creatorcontrib><creatorcontrib>Hwang, In-Chang</creatorcontrib><creatorcontrib>Kim, Hyue Mee</creatorcontrib><creatorcontrib>Park, Jiesuck</creatorcontrib><creatorcontrib>Choi, Hyejung</creatorcontrib><creatorcontrib>Choi, Hong-Mi</creatorcontrib><creatorcontrib>Yoon, Yeonyee E</creatorcontrib><creatorcontrib>Cho, Goo-Yeong</creatorcontrib><title>Age-dependent implications of left ventricular hypertrophy regression in patients with hypertension</title><title>Hypertension research</title><addtitle>Hypertens Res</addtitle><description>Left ventricular hypertrophy (LVH) is a significant risk factor for cardiovascular mortality and morbidity in patients with hypertension. However, the effect of age on LVH regression or persistence and its differential prognostic value remain unclear. Therefore, we investigated the clinical implications of LVH regression in 1847 patients with hypertension and echocardiography data (at baseline and during antihypertensive treatment at an interval of 6-18 months) according to age. LVH was defined as a left ventricular mass index (LVMI) &gt; 115 g/m and &gt;95 g/m in men and women, respectively. LVH prevalence at baseline was not different according to age (age &lt; 65 years: 42.6%; age ≥65 years: 45.7%; p = 0.187), but LVH regression was more frequently observed in the younger group (36.4% vs. 27.5%; p = 0.008). Spline curves and multiple linear regression analysis showed a significant relationship between reductions in systolic blood pressure and LVMI in the younger group (β = 0.425; p &lt; 0.001), but not the elderly group (β = 0.044; p = 0.308). LVH regression was associated with a lower risk of the study outcome (composite of cardiovascular death and hospitalization for heart failure) regardless of age. In conclusion, the association between the reduction in blood pressure and LVH regression was prominent in patients with age &lt; 65 years, but not in those with age ≥65 years. However, an association between LVH regression and lower risk of cardiovascular death and hospitalization for heart failure was observed regardless of patient age, suggesting the prognostic value of the LVH regression not only in the younger patients but also in elderly patients.</description><issn>0916-9636</issn><issn>1348-4214</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNo9kDtPwzAYRS0EoqXwBxiQRxaDX4ntsUK8pEosMFuJ87k1ygs7oeq_J6WF6Q733DschK4ZvWNU6PskmZSUUC4IZZliZHuC5kxITSRn8hTNqWE5MbnIZ-gipU9Kuc4MO0czobnQGWNz5JZrIBX00FbQDjg0fR1cMYSuTbjzuAY_4O-picGNdRHxZtdDHGLXb3Y4wjpCShOLQ4v7aTWBCW_DsDly0O7bS3TmizrB1TEX6OPp8f3hhazenl8fliviBBUDcdJkuRSsVFVRaqd0WWmfZ5XLpcqoyUQlvPRcg8mUVpX0uSpBa12KsmBccbFAt4ffPnZfI6TBNiE5qOuihW5Mlhtu6CRAsgnlB9TFLqUI3vYxNEXcWUbtXq49yLWTXPsr126n0c3xfywbqP4nfzbFD-rNd5Q</recordid><startdate>20240501</startdate><enddate>20240501</enddate><creator>Chu, Hyun-Wook</creator><creator>Hwang, In-Chang</creator><creator>Kim, Hyue Mee</creator><creator>Park, Jiesuck</creator><creator>Choi, Hyejung</creator><creator>Choi, Hong-Mi</creator><creator>Yoon, Yeonyee E</creator><creator>Cho, Goo-Yeong</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20240501</creationdate><title>Age-dependent implications of left ventricular hypertrophy regression in patients with hypertension</title><author>Chu, Hyun-Wook ; Hwang, In-Chang ; Kim, Hyue Mee ; Park, Jiesuck ; Choi, Hyejung ; Choi, Hong-Mi ; Yoon, Yeonyee E ; Cho, Goo-Yeong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c303t-c4956431b7dab8c78bd8f65dc64750953d3f4f28e95787d4f67be888b3ba12723</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chu, Hyun-Wook</creatorcontrib><creatorcontrib>Hwang, In-Chang</creatorcontrib><creatorcontrib>Kim, Hyue Mee</creatorcontrib><creatorcontrib>Park, Jiesuck</creatorcontrib><creatorcontrib>Choi, Hyejung</creatorcontrib><creatorcontrib>Choi, Hong-Mi</creatorcontrib><creatorcontrib>Yoon, Yeonyee E</creatorcontrib><creatorcontrib>Cho, Goo-Yeong</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Hypertension research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chu, Hyun-Wook</au><au>Hwang, In-Chang</au><au>Kim, Hyue Mee</au><au>Park, Jiesuck</au><au>Choi, Hyejung</au><au>Choi, Hong-Mi</au><au>Yoon, Yeonyee E</au><au>Cho, Goo-Yeong</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Age-dependent implications of left ventricular hypertrophy regression in patients with hypertension</atitle><jtitle>Hypertension research</jtitle><addtitle>Hypertens Res</addtitle><date>2024-05-01</date><risdate>2024</risdate><volume>47</volume><issue>5</issue><spage>1144</spage><epage>1156</epage><pages>1144-1156</pages><issn>0916-9636</issn><eissn>1348-4214</eissn><abstract>Left ventricular hypertrophy (LVH) is a significant risk factor for cardiovascular mortality and morbidity in patients with hypertension. However, the effect of age on LVH regression or persistence and its differential prognostic value remain unclear. Therefore, we investigated the clinical implications of LVH regression in 1847 patients with hypertension and echocardiography data (at baseline and during antihypertensive treatment at an interval of 6-18 months) according to age. LVH was defined as a left ventricular mass index (LVMI) &gt; 115 g/m and &gt;95 g/m in men and women, respectively. LVH prevalence at baseline was not different according to age (age &lt; 65 years: 42.6%; age ≥65 years: 45.7%; p = 0.187), but LVH regression was more frequently observed in the younger group (36.4% vs. 27.5%; p = 0.008). Spline curves and multiple linear regression analysis showed a significant relationship between reductions in systolic blood pressure and LVMI in the younger group (β = 0.425; p &lt; 0.001), but not the elderly group (β = 0.044; p = 0.308). LVH regression was associated with a lower risk of the study outcome (composite of cardiovascular death and hospitalization for heart failure) regardless of age. In conclusion, the association between the reduction in blood pressure and LVH regression was prominent in patients with age &lt; 65 years, but not in those with age ≥65 years. However, an association between LVH regression and lower risk of cardiovascular death and hospitalization for heart failure was observed regardless of patient age, suggesting the prognostic value of the LVH regression not only in the younger patients but also in elderly patients.</abstract><cop>England</cop><pmid>38238511</pmid><doi>10.1038/s41440-023-01571-w</doi><tpages>13</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0916-9636
ispartof Hypertension research, 2024-05, Vol.47 (5), p.1144-1156
issn 0916-9636
1348-4214
language eng
recordid cdi_proquest_miscellaneous_2929059141
source Alma/SFX Local Collection
title Age-dependent implications of left ventricular hypertrophy regression in patients with hypertension
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T19%3A22%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Age-dependent%20implications%20of%20left%20ventricular%20hypertrophy%20regression%20in%20patients%20with%20hypertension&rft.jtitle=Hypertension%20research&rft.au=Chu,%20Hyun-Wook&rft.date=2024-05-01&rft.volume=47&rft.issue=5&rft.spage=1144&rft.epage=1156&rft.pages=1144-1156&rft.issn=0916-9636&rft.eissn=1348-4214&rft_id=info:doi/10.1038/s41440-023-01571-w&rft_dat=%3Cproquest_cross%3E2929059141%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2929059141&rft_id=info:pmid/38238511&rfr_iscdi=true